falls (Page 2)

Flashpop Bionano Genomics (NASDAQ:BNGO) lost ~9% premarket Friday after the life sciences company announced an agreement with certain healthcare-focused institutional investors to sell ~17.5M shares of its common stock to raise roughly $10M in gross proceeds. As part of the agreement, the company will conduct a registered direct offering pricedContinue Reading

Investing.com – Ethereum was trading at $2,898.17 by 23:12 (03:12 GMT) on the Investing.com Index on Friday, down 10.25% on the day. It was the largest one-day percentage loss since November 9, 2022. The move downwards pushed Ethereum’s market cap down to $360.89B, or 17.62% of the total cryptocurrency marketContinue Reading

Investing.com – XRP was trading at $0.4215 by 20:45 (00:45 GMT) on the Investing.com Index on Friday, down 10.03% on the day. It was the largest one-day percentage loss since April 13. The move downwards pushed XRP’s market cap down to $23.6946B, or 1.14% of the total cryptocurrency market cap.Continue Reading

Investing.com – Litecoin was trading at $64.470 by 20:04 (00:04 GMT) on the Investing.com Index on Friday, down 10.65% on the day. It was the largest one-day percentage loss since April 12. The move downwards pushed Litecoin’s market cap down to $4.880B, or 0.23% of the total cryptocurrency market cap.Continue Reading

Investing.com – EOS was trading at $0.5038 by 19:37 (23:37 GMT) on the Investing.com Index on Thursday, down 10.10% on the day. It was the largest one-day percentage loss since April 13. The move downwards pushed EOS’s market cap down to $765.9048M, or 0.04% of the total cryptocurrency market cap.Continue Reading

Investing.com – Cardano was trading at $0.3658 by 19:39 (23:39 GMT) on the Investing.com Index on Thursday, down 10.10% on the day. It was the largest one-day percentage loss since July 4. The move downwards pushed Cardano’s market cap down to $13.2704B, or 0.63% of the total cryptocurrency market cap.Continue Reading

phototechno Canadian drug developer Apotex on Tuesday announced an agreement with Coherus Biosciences (NASDAQ:CHRS) to buy Canadian rights to the former’s cancer therapy toripalimab, marketed in the U.S. as Loqtorzi for head and neck cancer. Under the agreement, Apotex will hold exclusive Canadian rights to toripalimab, an anti-PD-1 monoclonal antibodyContinue Reading